Palatin Technologies PTN
NASDAQ PTN
$12.02 -0.31 (-2.51%)
At close: Sep 10, 2026 · 4:00 PM EDT

Palatin Technologies (PTN) Debt Ratio (2015 - 2024)

Palatin Technologies' (PTN) quarterly Debt Ratio came in at 0.24 in Q4 2024, up 193.35% on a YoY basis from 0.08 in Q1 2024, and down 26.09% quarter-over-quarter from 0.32 in Q3 2024.

Analysis

Palatin Technologies (PTN) Debt Ratio (2015 - 2024) Analysis & Trends

Palatin Technologies (PTN) has reported Debt Ratio for 7 consecutive years, with 0.24 the latest figure, recorded in Q4 2024.

  • For the quarter ending Q4 2024, Debt Ratio rose 193.35% year-over-year to 0.24; the trailing twelve-month figure through Dec 2024 stood at 0.24 (up 193.35% YoY), and the FY2024 full-year result was 0.1, down 17.25% from the prior year.
  • Debt Ratio slipped to 0.24 in Q4 2024 per PTN's latest filing, from 0.32 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.32 in Q3 2024 and bottomed at 0.08 in Q4 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 0.66
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 0.58
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 0.05
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 0.05
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn -
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 0.25
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -
10 Palatin Technologies 46.98 Mn 46.98 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 0.24
Sep 30, 2024 0.32
Jun 30, 2024 0.10
Mar 31, 2024 0.09
Dec 31, 2023 0.08
Jun 30, 2023 0.12
Jun 30, 2019 0.01
Mar 31, 2019 0.13
Dec 31, 2018 0.18
Sep 30, 2018 0.26
Jun 30, 2018 0.31
Mar 31, 2018 0.56
Dec 31, 2017 0.49
Sep 30, 2017 0.40
Jun 30, 2017 0.25
Mar 31, 2017 0.39
Dec 31, 2016 1.73
Sep 30, 2016 2.19
Jun 30, 2016 1.80
Jun 30, 2015 0.33